214 related articles for article (PubMed ID: 23609836)
1. [¹²³I]Iodometomidate imaging in adrenocortical carcinoma.
Kreissl MC; Schirbel A; Fassnacht M; Haenscheid H; Verburg FA; Bock S; Saeger W; Knoedler P; Reiners C; Buck AK; Allolio B; Hahner S
J Clin Endocrinol Metab; 2013 Jul; 98(7):2755-64. PubMed ID: 23609836
[TBL] [Abstract][Full Text] [Related]
2. Functional characterization of adrenal lesions using [123I]IMTO-SPECT/CT.
Hahner S; Kreissl MC; Fassnacht M; Haenscheid H; Bock S; Verburg FA; Knoedler P; Lang K; Reiners C; Buck AK; Allolio B; Schirbel A
J Clin Endocrinol Metab; 2013 Apr; 98(4):1508-18. PubMed ID: 23426614
[TBL] [Abstract][Full Text] [Related]
3. [123 I]Iodometomidate for molecular imaging of adrenocortical cytochrome P450 family 11B enzymes.
Hahner S; Stuermer A; Kreissl M; Reiners C; Fassnacht M; Haenscheid H; Beuschlein F; Zink M; Lang K; Allolio B; Schirbel A
J Clin Endocrinol Metab; 2008 Jun; 93(6):2358-65. PubMed ID: 18397978
[TBL] [Abstract][Full Text] [Related]
4. [131I]iodometomidate for targeted radionuclide therapy of advanced adrenocortical carcinoma.
Hahner S; Kreissl MC; Fassnacht M; Haenscheid H; Knoedler P; Lang K; Buck AK; Reiners C; Allolio B; Schirbel A
J Clin Endocrinol Metab; 2012 Mar; 97(3):914-22. PubMed ID: 22170726
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma.
Ardito A; Massaglia C; Pelosi E; Zaggia B; Basile V; Brambilla R; Vigna-Taglianti F; Duregon E; Arena V; Perotti P; Penna D; Terzolo M
Eur J Endocrinol; 2015 Dec; 173(6):749-56. PubMed ID: 26346137
[TBL] [Abstract][Full Text] [Related]
6. FDG-PET in adrenocortical carcinoma.
Becherer A; Vierhapper H; Pötzi C; Karanikas G; Kurtaran A; Schmaljohann J; Staudenherz A; Dudczak R; Kletter K
Cancer Biother Radiopharm; 2001 Aug; 16(4):289-95. PubMed ID: 11602999
[TBL] [Abstract][Full Text] [Related]
7. [11C]metomidate positron emission tomography of adrenocortical tumors in correlation with histopathological findings.
Hennings J; Lindhe O; Bergström M; Långström B; Sundin A; Hellman P
J Clin Endocrinol Metab; 2006 Apr; 91(4):1410-4. PubMed ID: 16403816
[TBL] [Abstract][Full Text] [Related]
8. 11C-metomidate PET imaging of adrenocortical cancer.
Khan TS; Sundin A; Juhlin C; Långström B; Bergström M; Eriksson B
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):403-10. PubMed ID: 12634969
[TBL] [Abstract][Full Text] [Related]
9. Metomidate-based imaging of adrenal masses.
Hahner S; Sundin A
Horm Cancer; 2011 Dec; 2(6):348-53. PubMed ID: 22124841
[TBL] [Abstract][Full Text] [Related]
10. Novel CYP11B-ligand [
Heinze B; Schirbel A; Nannen L; Michelmann D; Hartrampf PE; Bluemel C; Schneider M; Herrmann K; Haenscheid H; Fassnacht M; Buck AK; Hahner S
Eur J Nucl Med Mol Imaging; 2021 Dec; 49(1):301-310. PubMed ID: 34215922
[TBL] [Abstract][Full Text] [Related]
11. Imaging of adrenocortical metastases with [11C]metomidate.
Mitterhauser M; Dobrozemsky G; Zettinig G; Wadsak W; Vierhapper H; Dudczak R; Kletter K
Eur J Nucl Med Mol Imaging; 2006 Aug; 33(8):974. PubMed ID: 16721573
[No Abstract] [Full Text] [Related]
12. Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using (18)F-FDG positron emission tomography.
Werner RA; Kroiss M; Nakajo M; Mügge DO; Hahner S; Fassnacht M; Schirbel A; Bluemel C; Higuchi T; Papp L; Zsótér N; Buck AK; Bundschuh RA; Lapa C
Endocrine; 2016 Sep; 53(3):791-800. PubMed ID: 27138903
[TBL] [Abstract][Full Text] [Related]
13. Molecular Imaging in the Management of Adrenocortical Cancer: A Systematic Review.
Wong KK; Miller BS; Viglianti BL; Dwamena BA; Gauger PG; Cook GJ; Colletti PM; Rubello D; Gross MD
Clin Nucl Med; 2016 Aug; 41(8):e368-82. PubMed ID: 26825212
[TBL] [Abstract][Full Text] [Related]
14. Co-secretion of aldosterone and cortisol by an adrenocortical carcinoma.
Kurtulmus N; Yarman S; Azizlerli H; Kapran Y
Horm Res; 2004; 62(2):67-70. PubMed ID: 15218335
[TBL] [Abstract][Full Text] [Related]
15. A concomitant false-negative ¹⁸F-FDG PET imaging in an adrenocortical carcinoma and a high uptake in a corresponding liver metastasis.
Ghander C; Tissier F; Tenenbaum F; Silvera S; Ragazzon B; Bertherat J; Bertagna X; Dousset B; Richard B; Legmann P; Groussin L
J Clin Endocrinol Metab; 2012 Apr; 97(4):1096-7. PubMed ID: 22319030
[No Abstract] [Full Text] [Related]
16. Radiosynthesis of [124I]iodometomidate and biological evaluation using small-animal PET.
Kvaternik H; Wanek T; Hammerschmidt F; Zolle I; Aigner R; Kuntner C
Mol Imaging Biol; 2014 Jun; 16(3):317-21. PubMed ID: 24163019
[TBL] [Abstract][Full Text] [Related]
17. Aldosterone-producing adrenocortical carcinoma with prominent hepatic metastasis diagnosed by liver biopsy: a case report.
Ohashi K; Hayashi T; Sakamoto M; Iuchi H; Suzuki H; Ebisawa T; Tojo K; Sasano H; Utsunomiya K
BMC Endocr Disord; 2016 Jan; 16():3. PubMed ID: 26772981
[TBL] [Abstract][Full Text] [Related]
18. PET imaging of adrenal cortical tumors with the 11beta-hydroxylase tracer 11C-metomidate.
Bergström M; Juhlin C; Bonasera TA; Sundin A; Rastad J; Akerström G; Långström B
J Nucl Med; 2000 Feb; 41(2):275-82. PubMed ID: 10688111
[TBL] [Abstract][Full Text] [Related]
19. Fluorodesoxyglucose uptake in the remaining adrenal glands during the follow-up of patients with adrenocortical carcinoma: do not consider it as malignancy.
Leboulleux S; Deandreis D; Escourrou C; Al Ghuzlan A; Bidault F; Aupérin A; Travagli JP; Lumbroso J; Schlumberger M; Baudin E
Eur J Endocrinol; 2011 Jan; 164(1):89-94. PubMed ID: 20921280
[TBL] [Abstract][Full Text] [Related]
20. Investigating the Chemokine Receptor 4 as Potential Theranostic Target in Adrenocortical Cancer Patients.
Bluemel C; Hahner S; Heinze B; Fassnacht M; Kroiss M; Bley TA; Wester HJ; Kropf S; Lapa C; Schirbel A; Buck AK; Herrmann K
Clin Nucl Med; 2017 Jan; 42(1):e29-e34. PubMed ID: 27819856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
